The clinicopathological features and prognosis of gastric stump carcinoma following curative surgery

Liang CUI,Yan-tao TIAN,Tie-zheng ZHAO,Xin-xin SHAO,Yi-bin XIE,Ping ZHAO
DOI: https://doi.org/10.11877/j.issn.1672-1535.2015.13.03.18
2015-01-01
Abstract:Objective To evaluate the clinicopathological features and prognosis of gastric stump carcinoma (GSC) following curative surgery. Method The clinicopathological features and long-term survival rate of 63 pa-tients who had underwent curative gastrectomy for GSC from November 1999 to December 2014 were analyzed retro-spectively. Result Compared with malignant GSC, the benign ones following gastrectomy had a longer interval (24.8 years vs 8.9 years, P < 0.05), bigger tumor size (6.9 cm vs 4.3 cm, P < 0.05), and a higher proportion of GSC located in anastomosis (50% vs 26.3%, P < 0.05). As for Billroth Ⅱ vs Billroth Ⅰ, the Billroth Ⅱ reconstruction group had a longer interval (22.8 years vs 12.3 years, P < 0.05), bigger tumor size (6.73 cm vs 3.75 cm, P < 0.05), and a higher proportion of GSC located in anastomosis (52.4% vs 21%, P < 0.05). The 80-month survival rate of the stage Ⅲ group was significantly higher than that of the stage Ⅰ- Ⅱ group (64.7% vs 18.5%, P < 0.05). The 100-month survival rates of benign and malignant lesions following curative surgeries were similar (37.1% vs 40%, P >0.05), and the 80-month survival rates of Billroth Ⅱ and Billroth Ⅰ groups were also close (43.1% vs 27.3%, P >0.05). Conclusion The patients with GSC have different clinicopathological features as the initial diseases and the reconstruction methods vary. For patients with resectable GSC, long-term survival is associated with TNM staging, rather than the initial diseases and the reconstruction methods.
What problem does this paper attempt to address?